← Evidence map

ArticleNeuro-oncology advances

The dominant TP53 hotspot mutation in

Daniel F Marker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2022
2023
2024
2025
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 35047821